TIEDEMANN ADVISORS, LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 43 filers reported holding CTI BIOPHARMA CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
TIEDEMANN ADVISORS, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2017$196,000
-19.0%
73,1290.0%0.02%
-16.7%
Q2 2017$242,000
+72.9%
73,129
+118.7%
0.02%
+50.0%
Q1 2017$140,000–33,431–0.01%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q3 2017.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders